InvestorsHub Logo

couldbebetter

04/14/23 9:59 AM

#407284 RE: ziploc_1 #407277

I wonder if AMRN even knows what the status of full China approval really
is or what the capability of Eddingpharm actually is to bring about significant
sales of Vascepa. My hope remains that "if" a BP is interested in ultimately
acquiring AMRN, that BP may have a realistic game plan for China. I don't
even know if Eddingpharm is financially viable without an IPO. Hopefully,
the new BOD of AMRN will be able to figure out the real situation and
come up with a strategy after they find out what the situation really is.
Right now none of us even has a clue!